These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26374485)

  • 1. Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer.
    Chen Z; Lan X; Wu D; Sunkel B; Ye Z; Huang J; Liu Z; Clinton SK; Jin VX; Wang Q
    Nat Commun; 2015 Sep; 6():8323. PubMed ID: 26374485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids and the non-steroidal selective glucocorticoid receptor modulator, compound A, differentially affect colon cancer-derived myofibroblasts.
    Drebert Z; Bracke M; Beck IM
    J Steroid Biochem Mol Biol; 2015 May; 149():92-105. PubMed ID: 25666906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.
    Zheng Y; Ishiguro H; Ide H; Inoue S; Kashiwagi E; Kawahara T; Jalalizadeh M; Reis LO; Miyamoto H
    Mol Endocrinol; 2015 Oct; 29(10):1486-97. PubMed ID: 26322830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy.
    Orqueda AJ; Dansey MV; Español A; Veleiro AS; Bal de Kier Joffé E; Sales ME; Burton G; Pecci A
    Biochem Pharmacol; 2014 Jun; 89(4):526-35. PubMed ID: 24735610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect of non-steroid glucocorticoid receptor ligand CpdA on leukemia cell lines CEM and K562.
    Lesovaya EA; Yemelyanov AY; Kirsanov KI; Yakubovskaya MG; Budunova IV
    Biochemistry (Mosc); 2011 Nov; 76(11):1242-52. PubMed ID: 22117551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The autophagy receptor SQSTM1/p62 mediates anti-inflammatory actions of the selective NR3C1/glucocorticoid receptor modulator compound A (CpdA) in macrophages.
    Mylka V; Deckers J; Ratman D; De Cauwer L; Thommis J; De Rycke R; Impens F; Libert C; Tavernier J; Vanden Berghe W; Gevaert K; De Bosscher K
    Autophagy; 2018; 14(12):2049-2064. PubMed ID: 30215534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.
    Clarisse D; Van Wesemael K; Tavernier J; Offner F; Beck IM; De Bosscher K
    PLoS One; 2018; 13(5):e0197000. PubMed ID: 29738549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells.
    Riml S; Schmidt S; Ausserlechner MJ; Geley S; Kofler R
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S65-72. PubMed ID: 15017388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling.
    Kanai A; McNamara KM; Iwabuchi E; Miki Y; Onodera Y; Guestini F; Khalid F; Sagara Y; Ohi Y; Rai Y; Yamaguchi R; Tanaka M; Miyashita M; Ishida T; Sasano H
    Breast Cancer Res Treat; 2020 Feb; 180(1):97-110. PubMed ID: 31989378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts.
    Gossye V; Elewaut D; Bougarne N; Bracke D; Van Calenbergh S; Haegeman G; De Bosscher K
    Arthritis Rheum; 2009 Nov; 60(11):3241-50. PubMed ID: 19877072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay of the inflammatory and stress systems in a hepatic cell line: interactions between glucocorticoid receptor agonists and interleukin-6.
    Visser K; Smith C; Louw A
    Endocrinology; 2010 Nov; 151(11):5279-93. PubMed ID: 20881254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GR-independent down-modulation on GM-CSF bone marrow-derived dendritic cells by the selective glucocorticoid receptor modulator Compound A.
    Barcala Tabarrozzi AE; Andreone L; Deckers J; Castro CN; Gimeno ML; Ariolfo L; Berguer PM; Antunica-Noguerol M; Liberman AC; Vettorazzi S; Tuckermann JP; De Bosscher K; Perone MJ
    Sci Rep; 2016 Nov; 6():36646. PubMed ID: 27857212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A plant-derived glucocorticoid receptor modulator attenuates inflammation without provoking ligand-induced resistance.
    Gossye V; Elewaut D; Van Beneden K; Dewint P; Haegeman G; De Bosscher K
    Ann Rheum Dis; 2010 Jan; 69(1):291-6. PubMed ID: 19204014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Anti-Cancer Activity of the Novel Selective Glucocorticoid Receptor Agonists of the Phenylethanolamine Series.
    Zhidkova EM; Tilova LR; Fetisov TI; Kirsanov KI; Kulikov EP; Enikeev AD; Budunova IV; Badun GA; Chernysheva MG; Shirinian VZ; Yakubovskaya MG; Lesovaya EA
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Glucocorticoids in Breast Cancer Therapy.
    Mitre-Aguilar IB; Moreno-Mitre D; Melendez-Zajgla J; Maldonado V; Jacobo-Herrera NJ; Ramirez-Gonzalez V; Mendoza-Almanza G
    Curr Oncol; 2022 Dec; 30(1):298-314. PubMed ID: 36661673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
    Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
    Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma.
    Thomas AL; Coarfa C; Qian J; Wilkerson JJ; Rajapakshe K; Krett NL; Gunaratne PH; Rosen ST
    Nucl Recept Signal; 2015; 13():e006. PubMed ID: 26715915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis and modeling of glucocorticoid-controlled gene expression.
    Chen DW; Lynch JT; Demonacos C; Krstic-Demonacos M; Schwartz JM
    Pharmacogenomics; 2010 Nov; 11(11):1545-60. PubMed ID: 21121775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid receptors orchestrate a convergence of host and cellular stress signals in triple negative breast cancer.
    Posani SH; Gillis NE; Lange CA
    J Steroid Biochem Mol Biol; 2024 Oct; 243():106575. PubMed ID: 38950871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid receptor overexpression slightly shifts microRNA expression patterns in triple-negative breast cancer.
    Buschmann D; González R; Kirchner B; Mazzone C; Pfaffl MW; Schelling G; Steinlein O; Reithmair M
    Int J Oncol; 2018 Jun; 52(6):1765-1776. PubMed ID: 29620157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.